ARS Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
14.00
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.35
|
-0.50
|
-0.15
|
-42.86%
|
|
2022-06-30
|
-0.48
|
-0.55
|
-0.07
|
-14.58%
|
|
2022-03-31
|
-0.54
|
-0.70
|
-0.16
|
-29.63%
|
|
2021-12-31
|
-0.70
|
-0.67
|
0.03
|
4.29%
|
|
2021-09-30
|
-0.67
|
-0.65
|
0.02
|
2.99%
|
|
2021-06-30
|
-0.53
|
-0.70
|
-0.17
|
-32.08%
|
|
2021-03-31
|
-0.35
|
-0.54
|
-0.19
|
-54.29%
|
|
2020-12-31
|
-0.49
|
-1.37
|
-0.88
|
-179.59%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.75
|
|
2021-12-31
|
-2.56
|
|
2020-12-31
|
-2.07
|